3 unknown, 2 completed. 5 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Unknown 3, Completed 2 |
| Phase 1 | 2 | Completed 1, Unknown 1 |
Follow Adverse Drug Event: new trials by email Literature Review of Adverse Drug Event trials Research Report on Adverse Drug Event
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of GC101 TIL in Advanced Melanoma (BZ) GC101 TIL - Tumor Infiltrating Lymphocytes, Safety | Phase 1 / Phase 2 | Completed | Shanghai Juncell Therapeutics | 18 | 2023-11-08 | 2025-12-23 |
| Camrelizumab Combined With Chemotherapy for Recurrent or Advanced Cervical Neuroendocrine Carcinomas Drug therapy - Chemotherapy, Anti-pd-1 Antibody | Phase 2 | Unknown | Lei Li | 20 | 2020-11-15 | 2020-11-19 |
| TIL and Anti-PD1 in Metastatic Melanoma Nivolumab & Tumor Infiltrating Lymphocytes with/without Interferon-Alpha - Toxicity, Drug, Adverse Drug Event | Phase 1 / Phase 2 | Unknown | Leiden University | 34 | 2018-07-31 | 2023-12-12 |
| Efficacy and Adverse Effects of Prapchompoothaweep Remedy and Loratadine for Treatment in AR Patients Prapchompoothaweep remedy, Loratadine 10 Mg - Allergic Rhinitis, Adverse Drug Event | Phase 2 | Completed | Thammasat University | 72 | 2017-11-23 | 2018-08-22 |
| Phase II Study of Pazopanib as Second-line Treatment After Sunitinib in mRCC Patients pazopanib - Self Efficacy, Adverse Drug Event | Phase 2 | Unknown | Southern China Urology Cancer Consortium | 86 | 2014-07-01 | 2014-12-24 |
Drug-Related Side Effects and Adverse Reactions (5) · Melanoma (2) · Carcinoma, Renal Cell (1) · Rhinitis, Allergic (1) · Uterine Cervical Neoplasms (1)
Chemically-Induced Disorders (5) · Neoplasms (4) · Neoplasms by Site (4) · Neoplasms by Histologic Type (3) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Neoplasms, Germ Cell and Embryonal (2) · Neoplasms, Nerve Tissue (2) · Neuroectodermal Tumors (2) · Neuroendocrine Tumors (2) · Nevi and Melanomas (2) · Skin Diseases (2) · Skin Neoplasms (2) · Skin and Connective Tissue Diseases (2) · Urogenital Diseases (2)
Drug Therapy (1) · Loratadine (1) · Nivolumab (1) · pazopanib (1)
Lei Li (1) · Leiden University (1) · Shanghai Juncell Therapeutics (1) · Southern China Urology Cancer Consortium (1) · Thammasat University (1)
China (3) · Netherlands (1) · Thailand (1)
Ellen Kapiteijn, Dr. (1) · Jun Guo (1) · Lei Li, M.D. (1) · Mian Xie (1)